TABLE 5.
Variables Predicting the Presence of RV-PV Dysfunction
Model 1 |
Model 2 |
Model 3 |
||||
---|---|---|---|---|---|---|
C-Statistic | p Value | C-Statistic | p Value | C-Statistic | p Value | |
Model without metabolites | 0.68 | 0.72 | 0.82 | |||
Kynurenine | 0.76 | 0.007 | 0.80 | 0.004 | 0.86 | 0.03 |
Quinolinate | 0.72 | 0.05 | 0.75 | 0.07 | 0.85 | 0.13 |
Anthranilate | 0.71 | 0.11 | 0.74 | 0.10 | 0.87 | 0.01 |
Kynurenate | 0.75 | 0.04 | 0.79 | 0.01 | 0.88 | 0.02 |
IDO score | 0.74 | 0.01 | 0.79 | 0.006 | 0.87 | 0.01 |
Model 1: Consists of readily available clinical variables associated with pulmonary hypertension (age, sex, body mass index). Model 2: Adds pulmonary artery wedge pressure to model 1 variables. Model 3: Adds measured right ventricular ejection fraction; omits body mass index based on lack of significant association with any of the metabolite levels or pulmonary hypertension.
Abbreviations as in Table 2.